You just read:

Pharmascience Inc. contributes to the Montreal Heart Institute's COLchicine Cardiovascular Outcome Trial (COLCOT), a landmark study to benefit cardiovascular patients and the healthcare system

News provided by

Pharmascience Inc.

Nov 16, 2019, 12:00 ET